We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life sciences search specialist Coulter Partners has placed Francisco Salva as president and CEO of Azitra Inc. in Branford, CT. He replaces Rick Andrews who is retiring. Client partner Chris Palatucci led the assignment. “We are excited to bring in Francisco’s remarkable experience and leadership,” said Travis Whitfill, co-founder, executive director of advanced technology and chair, scientific
Life sciences search specialist Coulter Partners has placed Walter Miller as chief finance officer and Charles Woler as non-executive director of Optimapharm. Directors Mark Sharp and Irene Montgomery led the assignment. “It has been a privilege to partner with Optimapharm on two more key search assignments, following our collaboration to bring Andrew Copestake on board as CEO
Life sciences search specialist Coulter Partners has placed Brian O’Callaghan as chief executive officer of ObsEva, a clinical-stage biopharmaceutical company developing and commercializing novel therapies for women’s reproductive health. Client partner Nona Footz led the assignment. Mr. O’Callaghan succeeds Ernest Loumaye, who co-founded the firm in 2012. As ObsEva evolves from a development company toward
Life sciences search specialist Coulter Partners has formed a partnership with BioInnovation Institute (BII), the international incubator in Denmark for research-based innovation and entrepreneurship. The firm has been engaged to provide support for BII across three workstreams: providing assessment, coaching and development for the CEOs of start-up businesses in BII’s portfolio under the Creation House
Coulter Partners recently partnered with IMU Biosciences and is pleased to announce the placements of Dr. John Baker as Chief Executive Officer and Dr. Jason Brown as Chief Business Officer. Founder and former Chief Executive Officer Dr. Adam Laing will assume the roles of President and Chief Scientific Officer. IMU Biosciences is a biotechnology company
Coulter Partners successfully completed a search assignment for ArcticZymes Technologies ASA (OSE: AZT) and is pleased to announce the placement of Dr. Frank Mathias as Chair of the Board. Dr. Mathias is the CEO at Oxford Biomedica, a leading pure-play CDMO within the cell and gene therapy industry. Dr. Mathias was previously the CEO of
Coulter Partners recently partnered with MTIP and the Nitinotes Board to conduct a successful search for a new Chief Executive Officer (“CEO”) for Nitinotes. We are pleased to announce the placement of Lloyd Diamond in this key leadership role. Nitinotes is a pioneer in medical technology and a leader in Innovative Obesity Treatment. The Company
Coulter Partners recently partnered with CellCentric and is pleased to announce the placement of Andy Fergus as Chief Development Officer. Andy joined CellCentric in September 2024, and is Boston based. CellCentric’s mission is to transform outcomes for people living with specific cancers, notably relapsed refractory multiple myeloma, as quickly and effectively as possible. The clinical-stage
Coulter Partners recently partnered with QBiotics Group Limited (QBiotics) and is pleased to announce the placement of Stephen Doyle as Chief Executive Officer, and of two Non-executive Directors to its Board, namely Mark Fladrich and David Phillips QBiotics is an unlisted public Australian life sciences company that specializes in the discovery and development of novel
News
Top hires for Q3-2025
Top hires for Q2-2025
Coulter Partners: Fostering Digital Health connections on the Seine
Coulter Partners at BIA Women in Biotech: Driving diversity in Life Sciences leadership
Coulter Partners joins key discussion on HealthTech Boards at NHS Innovation Accelerator day
Coulter Partners at the BIA Life Science Leadership Summit: Fostering Board Excellence and UK Biotech Growth!
Coulter Partners attends LabCentral’s Luminescence: Rise & Fund event in Boston, MA
Leadership in MedTech: Key insights from our Paris roundtable
Coulter Partners co-hosts premier UK HealthTech Super Connector event
Coulter Partners attends Bio€quity Europe in Bruges, Belgium
Coulter Partners attends Danish Biotech Spring Gala
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024